Prevalence and prognostic value of epilepsy and Brugada syndrome

27 August 2023 (10:15 - 11:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Elena Rossetto

Milan (Italy)

7 More presentations in this session

Presentation thumbnail

An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results

Mrs P. Peltenburg (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Roles of atrial arrhythmias in triggering torsade de pointes in patients with acquired long QT syndrome

Doctor R. Tochibora (Gifu, JP)

Abstract Slides Video

Presentation thumbnail

Monitoring the electrophysiological effects of hydroquinidine non-invasively in patients with Brugada syndrome

Doctor J. Isbister (Sydney, AU)

Abstract Slides Video

Presentation thumbnail

Characterization of the cardiac and non-cardiac phenotype associated with genetic variants in KCNJ2

Doctor D. Abrams (Boston, US)

Abstract Slides Video

Presentation thumbnail

Interpretable machine learning model using Extreme Gradient Boosting with Nonnegative Matrix Factorization improves the accuracy of arrhythmic risk prediction in Brugada Syndrome

Professor G. Tse (Hong Kong, CN)

Abstract Slides

Access the full session

Session thumbnail

Ion channel diseases: risk stratification and treatment

The Event

Event poster

ESC Congress 2023

27 August 2023 10:15 CET

You may be interested in

Congress Presentation

Asymptomatic Brugada patients: long-term prognosis from a large prospective study.

Congress Presentation

Long-term outcome and therapeutic evolution in Brugada syndrome: A 30-year single-center experience

Congress Presentation

Prevalence of Brugada ECG pattern in patients with mood disorders: a longitudinal prospective cohort of 215 patients.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources